|
|
|
|
Preface |
|
|
Foreword: Outlook |
|
|
List of Contributors |
|
|
List of Reviewers |
|
Chapter 1 |
Introduction—General Considerations and International Perspectives Gunnar F. Nordberg, Bruce A. Fowler, Monica Nordberg, and Lars T. Friberg |
|
1 |
Metals and Health—An International Perspective |
|
2 |
Current Concerns Related to the Toxicology of Metals |
|
2.1 |
Expanding Current Industrial New Technological Uses of Metals |
|
2.2 |
Ecological and Natural Environmental Mobilization Processes |
|
2.3 |
Routes of Exposure |
|
2.4 |
Essentiality of Metals |
|
2.5 |
Human Health Effects |
|
2.6 |
Metal Carcinogenesis and Reproductive Toxicology |
|
2.7 |
Toxicokinetics and Metabolism |
|
2.8 |
Biological Monitoring |
|
2.9 |
Risk Assessment |
|
2.10 |
Interactions Among Metals |
|
Chapter 2 |
General Chemistry Sampling Analytical Methods and Speciation Rita cornelis and Monica Nordberg |
|
1 |
Definition of Metals |
|
2 |
The Periodic Table |
|
3 |
Compounds of Metallic Elements |
|
3.1 |
Covalent and Ionic Bonds |
|
3.2 |
Oxidation Number |
|
3.3 |
Inorganic Compounds |
|
3.4 |
Metal Complexes |
|
3.5 |
Organometallic Compounds |
|
4 |
Solubility |
|
5 |
Properties of Metal Irons |
|
5.1 |
Formation of Metal Irons |
|
5.2 |
Redox Potential |
|
5.3 |
Metal Irons as Lewis Acids |
|
5.4 |
Hydrolysis |
|
6 |
Other Aspects of Metal Chemistry of Biological and Toxicological Interest |
|
6.1 |
Main Group and Transition Metals |
|
6.2 |
Metal-Containing Biological Molecules |
|
6.2.1 |
Metalloporphyrins |
|
6.2.2 |
Non-Heme Iron Proteins |
|
6.2.3 |
Cobalt-Containing Biological Molecules |
|
6.2.4 |
Metalloenzymes and Metal-Activated Enzymes |
|
6.2.5 |
Metallothioneins |
|
6.2.6 |
Lead-Containing Biological MolecuIes |
|
7 |
Total Element Analysis, Elemental Speciation, and Metallomics |
|
8 |
Sampling and Sample Preparation |
|
8.1 |
General Considerations |
|
8.2 |
Air Water and Food |
|
8.2.1 |
Air |
|
8.2.2 |
Water |
|
8.2.3 |
Food |
|
8.3 |
Biological Monitoring |
|
9 |
Separation Techniques |
|
9.1 |
Liquid Chromatography |
|
9.2 |
Gas Chromatography |
|
9.3 |
Capillary Electrophoresis |
|
9.4 |
Gel Electrophoresis |
|
9.5 |
Precautionary Measures in Elemental Speciation |
|
10 |
Detection Methods |
|
10.1 |
General Aspects |
|
10.2 |
Current Methods for the Detection of Metals |
|
10.2.1 |
Atomic Absorption Spectrometry |
|
10.2.2 |
Atomic Fluorescence Spectrometry |
|
10.2.3 |
Atomic Emission Spectrometry |
|
10.2.4 |
Mass Spectrometry |
|
10.2.5 |
Electrochemical Methods |
|
10.2.6 |
Spectrophotometry |
|
10.2.7 |
Biosensors for Monitoring Metal Irons |
|
10.2.8 |
Direct Measurement of Metals in Solid Samples (Particle Characterization) |
|
10.2.9 |
Neutron Activation Analysis |
|
10.2.10 |
Spark Source Mass Spectrometry |
|
11 |
Calibration |
|
12 |
Reference Materials |
|
13 |
Quality Assurance |
|
13.1 |
Definitions |
|
13.2 |
Sources of Error |
|
13.3 |
Results of Interlaboratory Testing |
|
13.4 |
Elements of Quality Assurance |
|
13.5 |
Statistical Considerations |
|
13.6 |
Reporting of Quality Assurance Data |
|
14 |
Conclusions |
|
Chapter 3 |
Routes of Exposure, Dose, and Metabolism of Metals William S. Beckett Gunnar F Nordberg and Thomas W. Clarkson |
|
1 |
Introduction |
|
2 |
Exposure |
|
2.1 |
General Aspects |
|
2.2 |
Exposure by Inhalation |
|
2.3 |
Exposure Through Food and Drinking Water |
|
3 |
Deposition and Absorption |
|
3.1 |
Deposition and Absorption After Inhalation |
|
3.1.1 |
Absorption of Gases and Vapors |
|
3.1.2 |
Deposition of Particles |
|
3.1.3 |
Clearance of Particles from the Respiratory System |
|
3.2 |
Absorption After Ingestion |
|
3.4 |
Total Absorption |
|
4 |
Transport, Biotransformation, and Distribution |
|
5 |
Pathways and Mechanisms of Excretion |
|
5.1 |
Gastrointestinal Excretion |
|
5.2 |
Renal Excretion |
|
5.3 |
Excretion Rate—Biological Half-Time |
|
6 |
Toxicokinetic Models and Their Use for Establishment of Dose-Response and Dose-Effect Relationships |
|
6.1 |
One-Compartment Model |
|
6.1.1 |
Description |
|
6.1.2 |
Use of One-Compartment Model for Toxicokinetic (TK)-Toxicodynamic (TD) Modeling of Dose-Response or Dose-Effect Relationships |
|
6.2 |
Multicompartment Models and Physiologically Based Models |
|
6.2.1 |
Description of a Multicompartment Model for Cadmium |
|
6.2.2 |
Use of Multicompartment and Physiologically Based Models for TK/TD Modeling |
|
7 |
Use of Indicator Media for Estimation of Exposure or Critical Organ Concentration |
|
Chapter 4 |
Biological Monitoring and Biomarkers Antero Aitio Alfred Bernard Bruce A. Fowler and Gunnar F. Nordberg |
|
1 |
Introduction |
|
2 |
Sources of Preanalytical and Analytical Error |
|
3 |
Quality Assurance Reference Materials |
|
4 |
Specimens in Use; Urine Sample Standardization |
|
4.1 |
Urine |
|
4.2 |
Blood |
|
5 |
Reference Values |
|
6 |
Ethical Considerations |
|
7 |
Biomarkers of Exposure |
|
7.1 |
Analytical Approaches |
|
7.2 |
Speciation in Biomonitoring |
|
7.3 |
Kinetics and Sampling: Timing and Frequency |
|
7.4 |
Interpretation of Results |
|
7.5 |
Biomarkers of Exposure as a Complement to Industrial Hygiene Measurements |
|
8 |
Biomarkers of Effects |
|
8.1 |
Renal Toxicity Biomarkers |
|
8.2 |
Neurotoxicity Biomarkers |
|
8.3 |
Lung Toxicity Biomarkers |
|
8.4 |
Biomarkers for Other Target Organs |
|
8.5 |
Genotoxicity Biomarkers |
|
9 |
Future Trends |
|
Chapter 5 |
Selected Molecular Mechanisms of Metal Toxicity and Carcinogenicity Todd Davidson Qingdong Ke and Max Costa |
|
1 |
Transport of Toxic Metals by Molecular/Ionic Mimicry of Essential Compounds |
|
1.1 |
Introduction |
|
1.2 |
Iron |
|
1.3 |
Zinc |
|
1.4 |
Phosphate and Sulfate Mimics |
|
1.5 |
Organic Complexes |
|
1.6 |
Metal-Anion Complexes |
|
1.7 |
Calcium Channels |
|
1.8 |
Summary |
|
2 |
Interference with the Functions of Essential Metals by Toxic Metals |
|
2.1 |
Introduction |
|
2.2 |
Calcium |
|
2.3 |
Zinc |
|
2.4 |
Magnesium |
|
2.5 |
Iron |
|
2.6 |
Copper |
|
3 |
Toxic Metal-Binding Molecules |
|
3.1 |
Introduction |
|
3.2 |
Metallothioneins (MTs) |
|
3.3 |
Glutathione |
|
3.4 |
Summary |
|
4 |
Mutagenic and Genotoxic Effects of Metals |
|
4.1 |
Introduction |
|
4.2 |
Mutagenicity and Genotoxicity of Nickel Compounds |
|
4.3 |
Mutagenicity and Genotoxicity of Chromium Compounds |
|
4.4 |
Mutagenicity and Genotoxicity of Arsenic |
|
4.5 |
Mutagenicity and Genotoxicity of Cadmium |
|
5 |
Epigenetic Effects of Metal Compounds |
|
5.1 |
Introduction |
|
5.2 |
Epigenetic Events in the Development of Cancer |
|
5.2.1 |
DNA Methylation |
|
5.2.2 |
Histone Modifications |
|
5.3 |
Impacts of Metal Compounds on Epigenetics |
|
5.3.1 |
As |
|
5.3.2 |
Cd |
|
5.3.3 |
Ni |
|
6 |
Effects of Metals on Cell Signaling Pathways and Gene Expression |
|
6.1 |
Introduction |
|
6.2 |
Signal Transduction Pathways Affected by Metal Compounds |
|
6.2.1 |
ROS |
|
6.2.2 |
MAPK |
|
6.2.3 |
PI3K/Akt |
|
6.2.4 |
HIF-1 |
|
6.2.5 |
NF-kB |
|
6.2.6 |
NFAT |
|
6.2.7 |
AP-1 |
|
6.3 |
Impacts of Metal Compounds on Signal Transduction Pathways and Gene Expression |
|
6.3.1 |
As |
|
6.3.2 |
Cd |
|
6.3.3 |
Cr |
|
6.3.4 |
Co |
|
6.3.5 |
Ni |
|
6.3.6 |
Other Metals |
|
Chapter 6 |
General Considerations of Dose-Effect and Dose-Response Relationships Daphne B. Moffett Hisham A. El-Masri and Bruce A. Fowler |
|
1 |
General Aspects of Dose-Response Relationships |
|
1.1 |
Use of the Terms Effect and Response |
|
1.2 |
Interrelationships Among Dose, Effect, and Response |
|
1.3 |
Definitions of Dose and Response |
|
2 |
Modeling of Dose-Response Relationships |
|
2.1 |
The Shape of Dose-Response Curves: S, Hormesis, U-Shaped |
|
2.2 |
The Sigmoid Curve |
|
2.3 |
Hormesis—Inverted U- or J-Shaped Curves |
|
2.4 |
U-Shaped Curves and Essentiality |
|
3 |
Modeling the Data |
|
3.1 |
Biological Basis for Modeling |
|
4 |
Species-to-Species Extrapolations |
|
5 |
Risk Assessment and Dose-Response Relationships |
|
5.1 |
NOAEL/LOAEL |
|
5.2 |
Benchmark Dose |
|
5.3 |
Data Types and Benchmark Dose |
|
6 |
Dose-Response in an Era of -Omics |
|
Chapter 7 |
Interactions in Metal Toxicology Gunnar F. Nordberg, Lars Gerhardsson, Karin Broberg Moiz Mumtaz Patricia Ruiz and Bruce A. Fowler |
|
1 |
Introduction |
|
2 |
Age, Sex, Drugs, and Some Other Factors |
|
2.1 |
Influence of Drugs, Alcohol, and Tobacco on Metal Metabolism and Toxicity |
|
2.1.1 |
Drugs |
|
2.1.2 |
Alcohol and Tobacco |
|
2.2 |
Influence of Age and Sex on Metal Toxicity |
|
2.2.1 |
Age |
|
2.2.2 |
Sex |
|
2.3 |
Influence of Some Other Factors on Metal Metabolism and Toxicity |
|
3 |
Gene–Environment Interactions for Metals |
|
3.1 |
Genes of Concern |
|
3.2 |
Design of Gene–Environment Interaction Studies |
|
3.3 |
Interactions for Specific Metals |
|
3.3.1 |
Arsenic |
|
3.3.2 |
Beryllium and Cobalt |
|
3.3.3 |
Cadmium |
|
3.3.4 |
Lead |
|
3.3.5 |
Mercury |
|
3.3.6 |
Nickel |
|
3.3.7 |
Platinum |
|
3.4 |
Conclusions |
|
4 |
Metal-Metal Interactions (Noncarcinogenic Effects) |
|
4.1 |
Arsenic and Other Metals |
|
4.2 |
Interactions Between Cadmium and Other Metals |
|
4.3 |
Interactions Between Lead and Other Metals |
|
4.4 |
Hg and Other Metals |
|
4.5 |
Molybdenum-Copper-Zinc Interactions |
|
4.6 |
Interactions Between Thallium and Potassium |
|
5 |
Metal-Metal Interactions in Carcinogenesis |
|
5.1 |
Arsenic |
|
5.2 |
Chromium |
|
5.3 |
Iron |
|
5.4 |
Lead |
|
5.5 |
Nickel |
|
5.6 |
Selenium |
|
5.7 |
Zinc |
|
6 |
Risk Assessment of Mixtures of Metals |
|
6.1 |
Introduction |
|
6.2 |
Toxicity Assessment of Mixtures |
|
6.2.1 |
The Mixture of Concern |
|
6.2.2 |
The Similar Mixture Approach |
|
6.2.3 |
The Hazard Index Approach |
|
6.2.4 |
The Target-Organ Toxicity Dose(TTD) |
|
6.3 |
A Weight-of-Evidence (WOE) Method |
|
6.3.1 |
Direction of Interaction |
|
6.3.2 |
Mechanistic Understanding |
|
6.3.3 |
Toxicological Significance |
|
6.4 |
Perspectives and Future Needs |
|
Chapter 8 |
Epidemiological Methods for Assessing Dose-Response and Dose-Effect Relationships Tord Kjellstrom and Philippe Grandjean |
|
1 |
Epidemiological Measurement of Occurrence of Health Effects |
|
2 |
Observational Studies and Modeling Studies of Dose-Response Relationships |
|
3 |
Study Design |
|
4 |
Data Collection |
|
4.1 |
Measurement of Dose |
|
4.2 |
Measurement of Effect and Response |
|
5 |
Data Analysis |
|
6 |
Inference |
|
Chapter 9 |
Essential Metals: Assessing Risks from Deficiency and Toxicity George C. Becking, Monica Nordberg, and Gunnar F. Nordberg |
|
1 |
Introduction |
|
2 |
Basic Concepts |
|
2.1 |
Definition of an AROI (Acceptable |
|
2.1.1 |
Groups with Special Sensitivity/Resistance |
|
2.2 |
Other Concepts Used in Risk Assessment of Essential Metals |
|
2.2.1 |
Toxicological Terms |
|
2.2.2 |
Nutritional Terms: Definitions and Approaches
Used to Assess Individual and Population Requirements for |
|
3 |
Effects of Deficiency and Toxicity |
|
3.1 |
Factors Affecting Dose-Response Relationships |
|
3.1.1 |
Homeostatic Mechanisms |
|
3.1.2 |
Bioavailability, Speciation, and Interactions |
|
3.2 |
Basic Principles for Classifying Effect |
|
3.3 |
Examples of Effects of Varying Severity |
|
3.3.1 |
Lethal Deficiency |
|
3.3.2 |
Deficiency—Clinical Disease |
|
3.3.3 |
Subclinical Biomarkers of Deficiency with or without Clinical Significance |
|
3.3.4 |
Lethal Toxic Effects |
|
3.3.5 |
Toxic Effects with Clinical Significance |
|
3.3.6 |
Subclinical Toxic Effects with or without Functional Significance— Biomarkers of Critical Effect |
|
4 |
Summary of Principles for Human Risk Assessment
of Exposures to |
|
4.1 |
Application of Principles for Determination of AROI |
|
5 |
Estimation of AROI |
|
6 |
Conclusions |
|
Chapter 10 |
Carcinogenicity of Metal Compounds Qingdong Ke, Max Costa, and George Kazantzis |
|
1 |
Principal Metals Showing Carcinogenic Effects |
|
1.1 |
Nickel |
|
1.1.1 |
Epidemiological Observations |
|
1.1.2 |
Animal Models |
|
1.1.3 |
Evaluation |
|
1.2 |
Chromium |
|
1.2.1 |
Epidemiological Observations |
|
1.2.2 |
Animal Models |
|
1.2.3 |
Short-Term Tests |
|
1.2.4 |
Evaluation |
|
1.3 |
Arsenic |
|
1.3.1 |
Epidemiological Observations |
|
1.3.2 |
Animal Models |
|
1.3.3 |
Short-Term Tests |
|
1.3.4 |
Evaluation |
|
1.4 |
Cadmium |
|
1.4.1 |
Epidemiological Observations |
|
1.4.2 |
Animal Models |
|
1.4.3 |
Short-Term Tests |
|
1.4.4 |
Evaluation |
|
1.5 |
Beryllium |
|
1.5.1 |
Epidemiology Observations |
|
1.5.2 |
Animal Models |
|
1.5.3 |
Evaluation |
|
1.6 |
Lead |
|
1.6.1 |
Epidemiological Observations |
|
1.6.2 |
Animal Models and Short-Term Tests |
|
1.6.3 |
Evaluation |
|
1.7 |
Cobalt |
|
1.8 |
Iron |
|
1.9 |
Manganese |
|
1.10 |
Platinum |
|
1.11 |
Titanium |
|
2 |
Principal Metals Showing Mutagenic Effects |
|
2.1 |
Nickel |
|
2.2 |
Chromium |
|
2.3 |
Arsenic |
|
2.4 |
Cadmium |
|
Chapter 11 |
Immunotoxicology of Metals Per Hultman |
|
1 |
Introduction |
|
1.1 |
Development of the Concept Metal Lmmunotoxicology |
|
1.2 |
Overview of Mechanisms in Immunotoxicology |
|
1.3 |
Dose-Response Considerations in Metal Immunotoxicology |
|
2 |
Immunosuppression Induced by Metals |
|
2.1 |
General Considerations |
|
2.2 |
In Vitro Studies |
|
2.3 |
In Vivo Studies |
|
2.4 |
Experimental Host-Resistance Challenge Systems |
|
2.5 |
Clinical Immunosuppressive Effects |
|
3 |
Essential Metals and the Immune System |
|
4 |
Hypersensitivity Induced by Metals |
|
4.1 |
General Considerations |
|
4.2 |
Type I Hypersensitivity (Anaphylacticor Immediate Hypersensitivity) |
|
4.3 |
Type II Hypersensitivity (Antibody-Mediated—IgG or IgM—Reactions Against Cells or Matrix) |
|
4.4 |
Type III Hypersensitivity (Immune-Complex Mediated Reactions) |
|
4.5 |
Type IV Hypersensitivity (Cell-Mediated Reactions) |
|
4.6 |
Relation Between Atopy and Metal Hypersensitivity |
|
5 |
Metals Causing Hypersensitivity Reactions |
|
5.1 |
Beryllium |
|
5.2 |
Chromium |
|
5.3 |
Cobalt |
|
5.4 |
Gold |
|
5.5 |
Mercury |
|
5.6 |
Nickel |
|
5.7 |
Multiple Metal Exposure Relatedto Prosthetic Devices |
|
5.8 |
The Platinum Group of Elements (Palladium, Platinum, Rhodium) |
|
6 |
Interaction Between Metals and Proteins |
|
6.1 |
Introduction |
|
6.2 |
Mechanisms of Interaction Between T Cells and Metal Irons |
|
7 |
Other Interactions Between Metals and Proteins— Implications for Autoimmunity |
|
8 |
Nonspecific Immunostimulation Induced by Metals: The Examples of Pb and Hg |
|
9 |
Metal-Induced Autoimmunity |
|
10 |
Acceleration and Aggravation of Autoimmunity by Xenobiotics |
|
10.1 |
General Considerations |
|
10.2 |
Acceleration of Spontaneous Autoimmune Diseases by Hg |
|
10.3 |
Acceleration of Spontaneous Autoimmune Diseases by Cadmium and Lead |
|
10.4 |
Comments on the Autoimmune Effects of Metals |
|
Chapter 12 |
Reproductive and Developmental Toxicity of Metals Pietro Apostoli, Spomenka Tellsman and Polly R. Sager |
|
1 |
Introduction |
|
2 |
Male Reproductive Effects |
|
2.1 |
Lead |
|
2.2 |
Mercury |
|
2.3 |
Cadmium |
|
2.4 |
Manganese |
|
2.5 |
Chromium |
|
2.6 |
Nickel |
|
2.7 |
Arsenic |
|
3 |
Female Reproductive Effects |
|
3.1 |
Lead |
|
3.2 |
Mercury |
|
3.3 |
Cadmium |
|
3.4 |
Manganese |
|
3.5 |
Chromium |
|
3.6 |
Nickel |
|
3.7 |
Arsenic |
|
3.8 |
Platinum |
|
3.9 |
Mixed Metal Exposure |
|
4 |
Developmental Effects of Prenatal Exposure |
|
4.1 |
Lead |
|
4.2 |
Mercury |
|
4.3 |
Cadmium |
|
4.4 |
Chromium |
|
4.5 |
Nickel |
|
4.6 |
Arsenic |
|
4.7 |
Vanadium |
|
4.8 |
Uranium |
|
4.9 |
Aluminum |
|
4.10 |
Lithium |
|
5 |
Developmental Effects from Neonatal Exposure |
|
5.1 |
Lead |
|
5.2 |
Mercury |
|
5.3 |
Cadmium |
|
5.4 |
Nickel |
|
5.5 |
Arsenic |
|
5.6 |
Aluminum |
|
5.7 |
Mixed Metal and Multichemical Exposure |
|
Chapter 13 |
Ecotoxicology of Metals—Sources Transport, and Effects in the Ecosystem Poul Bjerregaard and Ole Andersen |
|
1 |
Sources for Metal Emission |
|
1.1 |
Direct Emissions of Metals into Nature |
|
1.1.1 |
Emissions to the Atmosphere |
|
1.1.2 |
Emissions into Water |
|
1.1.3 |
Emissions to Soil |
|
1.2 |
Indirect Mobilization of Metals |
|
1.2.1 |
Acid Rain |
|
1.2.2 |
Oxygen Depletion |
|
1.2.3 |
Pyrite Oxidation |
|
2 |
The BiogeochemicaI Transport of Metals |
|
2.1 |
Atmospheric Transport |
|
2.2 |
Metal Speciation in Water |
|
2.3 |
Metal Transport in the Ocean |
|
2.4 |
Transport of Metals in Freshwater and Estuaries |
|
2.5 |
Metals in Sediments |
|
3 |
Uptake and Accumulation of Metals |
|
3.1 |
Bioavailability, Uptake, Accumulation, and Elimination |
|
3.2 |
Metal Transport in Aquatic Food Chains |
|
4 |
Defense Against and Storage of Metals |
|
4.1 |
Metal Toxicity and Defense Systems in Plants |
|
5 |
Toxicity of Metals in Ecosystems |
|
6 |
Risk Assessment of Metals |
|
6.1 |
The Aim of Ecotoxieological Risk Assessment |
|
6.2 |
Integrated Risk Assessment |
|
6.3 |
Methods of Ecotoxicology |
|
6.4 |
Practical Risk Management |
|
6.5 |
Biomarkers as Hazard Indicators in Ecotoxicological Risk Assessment |
|
7 |
Monitoring Metal Pollution—Biomonitoring |
|
7.1 |
Mussel Watch |
|
7.2 |
Other Monitoring Organisms |
|
8 |
Ecotoxicology of Individual Metals |
|
8.1 |
Alumina |
|
8.2 |
Antimony |
|
8.3 |
Arsenic |
|
8.3 |
Cadmium |
|
8.3.1 |
Background Levels and Emissions |
|
8.3.2 |
Uptake in Organisms |
|
8.3.3 |
Contamination with Cadmium |
|
8.3.4 |
Cadmium’s Toxicity in Water |
|
8.3.5 |
Cadmium in Agricultural Soil and Uptake of Cadmium into Plants |
|
8.3.6 |
Implication for Human Health |
|
8.4 |
Cobalt |
|
8.5 |
Chromium |
|
8.6 |
Copper |
|
8.7 |
Iron |
|
8.8 |
Lead |
|
8.8.1 |
Lead in Ammunition |
|
8.8.2 |
Effects in Birds and Mammals |
|
8.9 |
Manganese |
|
8.10 |
Mercury |
|
8.10.1 |
Background Concentrations, Uses, and Emissions |
|
8.10.2 |
The Transformation of Mercury in Nature |
|
8.10.3 |
The Global Mercury Flux |
|
8.10.4 |
Uptake of Mercury in Organisms and Transport in Food Webs |
|
8.10.5 |
Effects of Mercury in Wildlife |
|
8.10.6 |
Implications for Human Health |
|
8.11 |
Molybdenum |
|
8.12 |
Nickel |
|
8.13 |
Selenium |
|
8.14 |
Silver |
|
8.15 |
Tin |
|
8.15.1 |
Inorganic Tin |
|
8.15.2 |
Tributyltin (TBT) |
|
8.16 |
Vanadium |
|
8.17 |
Zinc |
|
8.18 |
Radioactive Metals |
|
8.18.1 |
Cesium |
|
8.18.2 |
Polonium |
|
8.18.3 |
Strontium |
|
8.18.4 |
Transuranic Metals |
|
Chapter 14 |
Risk Assessment Gunnar F. Nordberg And Bruce A. Fowler |
|
1 |
Introduction |
|
2 |
Exposure and Dose Assessment |
|
2.1 |
Exposure and Dose Terminology |
|
2.2 |
Exposure, Applied/Inhaled Dose, Daily Intake |
|
2.3 |
Absorbed Dose, Internal Dose |
|
2.4 |
Dose/Concentration in Critical Organ and Critical Target |
|
2.5 |
Use of Biomarkers in Estimating Concentration in Critical Organ and Critical Target Dose |
|
3 |
Hazard Identification |
|
3.1 |
Speciation |
|
3.2 |
Human Data |
|
3.3 |
Data from Studies on Acute and Chronic Toxicity in Animals, Cells, and Molecular Systems in Vitro |
|
3.3.1 |
IARC Group 2 |
|
3.3.2 |
IARC Group 2A: The Agent is Probably Carcinogenic to Humans |
|
3.3.3 |
IARC Group 2B: The Agent is Possibly Carcinogenic to Humans |
|
3.4 |
Classification According to the European Union |
|
3.5 |
Classification According to the USEPA |
|
3.6 |
Classification According to the American Conference of Governmental Industrial Hygienists Inc. |
|
4 |
Dose-Effect and Dose-Response Assessment |
|
4.1 |
Concepts in Quantitative Toxicological Analysis |
|
4.1.1 |
Dose Effect and Dose Response |
|
4.1.2 |
Critical Concentration, Critical Organ, Critical Effect, and No-Observed-Effect Level |
|
4.1.3 |
Benchmark Dose |
|
4.1.4 |
The Critical Concentration on a Population Basis |
|
4.2 |
Based on Short-Term and Long-Term Studies in Animals |
|
4.2.1 |
Threshold-Type Critical Effects |
|
4.2.2 |
Carcinogenesis and Other Nonthreshold Effects |
|
4.3 |
Probabilistic Estimation of Dose-Response Relationships by Toxicokinetic (TK) and Toxicodynamic (TD) Modeling |
|
4.3.1 |
Deterministic or Threshold-Type Effects |
|
4.3.2 |
Stochastic or Nonthreshold Effects |
|
4.4 |
Based on Epidemiological Studies |
|
4.4.1 |
Sensitive Groups |
|
4.4.2 |
Carcinogenic Effects |
|
4.5 |
Simplified Approach as an Alternative to Risk Assessment |
|
5 |
Risk Characterization |
|
6 |
Risk Management and Risk Communication |
|
6.1 |
Managing Human Exposures by Emission Control, Substitution, Labeling, or Restrictions in Use |
|
6.2 |
Controlling Human Exposures by Guidelines and Legislated Permissible Exposure Levels |
|
6.3 |
Risk Communication |
|
Chapter 15 |
Diagnosis and Treatment of Metal Poisoning—General Aspects George Kazantzis |
|
1 |
Clinical Effects |
|
1.1 |
General Considerations |
|
1.2 |
Exposure Pattern and Clinical Effect |
|
1.3 |
Acute Clinical Effects of Metals |
|
1.3.1 |
Gastrointestinal Effects |
|
1.3.2 |
Respiratory Effects |
|
1.3.3 |
Cardiovascular Effects |
|
1.3.4 |
Effects on the Central Nervous System |
|
1.3.5 |
Renal Effects |
|
1.3.6 |
Hemopoietic Effects |
|
1.4 |
Chronic Clinical Effects of Metal Toxicity |
|
1.4.1 |
Gastrointestinal Effects |
|
1.4.2 |
Hepatic Effects |
|
1.4.3 |
Respiratory Effects |
|
1.4.4 |
Effects on the Nervous System |
|
1.4.5 |
Renal Effects |
|
1.4.6 |
Hemopoietic Effects |
|
2 |
Diagnosis of Metal Poisoning |
|
2.1 |
History of Exposure |
|
2.2 |
Clinical Features |
|
2.3 |
Toxicological Analysis |
|
2.4 |
Biochemical Investigation |
|
2.5 |
Physiological Investigation |
|
3 |
Treatment |
|
3.1 |
Prevention of Further Absorption |
|
3.1.1 |
Removal from Exposure |
|
3.1.2 |
Minimizing Absorption from the Gastrointestinal Tract |
|
3.2 |
General Supportive Therapy |
|
3.2.1 |
Maintenance of Respiration and Circulation |
|
3.2.2 |
Maintenance of Water and Electrolyte Balance |
|
3.2.3 |
Control of Nervous System Effects |
|
3.3 |
Elimination of Absorbed Poison |
|
3.3.1 |
Diuresis |
|
3.3.2 |
Biliary Excretion |
|
3.3.3 |
Dialysis |
|
3.3.4 |
Exchange Transfusion |
|
3.4 |
Inactivation of the Absorbed Poison |
|
3.5 |
Chelation Therapy |
|
3.5.1 |
Dimercaprol |
|
3.5.2 |
Calcium Disodium Edetate (Calcium EDTA) |
|
3.5.3 |
Penicillamine (Cuprimine) |
|
3.5.4 |
Triethylene Tetramine (Trien, TETA) |
|
3.5.5 |
Desferrioxamine (DFOA) |
|
3.5.6 |
Deferiprone(LI) |
|
3.5.7 |
Diethylenetriaminepentaacetic Acid (DTPA) |
|
3.5.8 |
Diethyldithiocarbamate(DEDTC) |
|
3.5.9 |
Combinations of chelating Agents |
|
3.6 |
Modification of Response |
|
3.6.1 |
Modification of Tissue Response |
|
3.6.2 |
Modification of Biochemical Status |
|
Chapter 16 |
Principles for Prevention of the Toxic Effects of Metals Philip J. Landrigan, David Kotelchuck, and Philippe Grandjean |
|
1 |
Introduction |
|
2 |
General Principles for Prevention of the toxic Effects of metals |
|
2.1 |
Hazard Identification |
|
2.1.1 |
Lead |
|
2.1.2 |
Methylmercury |
|
2.1.3 |
Arsenic |
|
2.2 |
Reduction of Exposure |
|
3 |
Prevention of the Effects of Metal Toxicity in the Work Environment |
|
3.1 |
General considerations |
|
3.2 |
Reduction of Exposure |
|
3.2.1 |
Elimination of Unnecessary Uses and Substitution of Safer Materials |
|
3.2.2 |
Reduced Use of Toxic Metals in Plant and Manufacturing Design |
|
3.2.3 |
Other Technical Control Measures |
|
3.2.4 |
Local Exhaust Ventilation |
|
3.2.5 |
General Room Ventilation |
|
3.2.6 |
Housekeeping |
|
3.2.7 |
Influence of Personal Hygiene on Metal Absorption and Toxicity |
|
3.2.8 |
Reduction of Worker Contact with Toxic Metals and Personal Protective Equipment |
|
3.3 |
Monitoring of the Work Environment |
|
3.3.1 |
Air Sampling Strategy in the Workspace |
|
3.3.2 |
Sampling Technique |
|
3.3.3 |
Analysis |
|
3.3.4 |
Biological Monitoring |
|
3.3.5 |
Health Examinations |
|
3.4 |
Training |
|
3.5 |
Authority |
|
4 |
Prevention of the Effects of Metal Toxicity in the General Environments |
|
4.1 |
General Considerations |
|
4.2 |
The Unique Vulnerability of Infants and Children to Poisoning by Metals |
|
4.3 |
Reduction of Exposure |
|
4.3.1 |
Elimination or Reduction of Use |
|
4.3.2 |
Source Control |
|
4.3.3 |
Routes of Environmental Contamination by Metals |
|
4.4 |
Environmental Monitoring |
|
4.5 |
Public Education |
|
4.6 |
Regulatory Authority |
|
5 |
Perspectives on Precaution and Prevention |
|
5.1 |
Populations at Risk |
|
5.2 |
Widening Implications of Subclinical Toxicity |
|
5.3 |
Precautionary Approaches |
|
Chapter 17 |
Aluminum Bengtsjögren, Anders Iregren, Carl-Gustaf Elinder, and Robert A. Yokel |
|
1 |
Physical and Chemical Propertiea |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Use |
|
4 |
Dietary, Environmental, and Occupational Exposure |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Monitoring |
|
6 |
EFFECTS |
|
6.1 |
Gastrointestinal Symptoms |
|
6.2 |
Restrictive Pulminory Disease |
|
6.3 |
Obstructive Pulminory Disease |
|
6.4 |
Central Nervous System |
|
6.4.1 |
Dialysis Encephalopathy |
|
6.4.2 |
Other Medical Aluminum Exposures |
|
6.4.3 |
Neurobehavioral Effects of Occupational Aluminum Exposure |
|
6.4.4 |
Alzheimer’s Disease |
|
6.5 |
Bone |
|
6.6 |
Hematopoietic Tissue |
|
6.7 |
Skin |
|
6.8 |
Allergic Effects |
|
6.9 |
Coronary Heart Disease |
|
6.10 |
Carcinogenic Effects |
|
7 |
Other Aluminum Compounds |
|
8 |
Recommendations |
|
Chapter 18 |
Antimony Carolyn A Tylenda and Bruce A Fowler |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Historical Background |
|
3.2 |
Production |
|
3.3 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Food and Daily Intake |
|
4.1.2 |
Air, Soil, and Water |
|
4.1.3 |
Tobacco |
|
4.2 |
Working Environment |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Indigestion |
|
5.2 |
Distribution |
|
5.2.1 |
Animals |
|
5.2.2 |
Humans |
|
5.3 |
Excretion |
|
5.3.2 |
Animals |
|
5.3.2 |
Humans |
|
5.4 |
Biological Half-Life |
|
5.4.1 |
Animals |
|
5.4.2 |
Humans |
|
6 |
Biological Monitoring |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Animals |
|
7.1.1 |
Local Effects and Dose-Response Relationships |
|
7.1.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2 |
Humans |
|
7.2.1 |
Local Effects and Dose-Response Relationships |
|
7.2.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2.3 |
Adverse Effects During Antimony Treatment |
|
8 |
Carcinogenic and Genotoxic Effects |
|
Chapter 19 |
Arsenic Bruce A. Fowler C.H. Selene J. Chou Robert L. and J. Chien |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
Food and Daily Intake |
|
4.2 |
Water |
|
4.3 |
Soil |
|
4.4 |
Air |
|
4.5 |
Tobacco |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.1.3 |
Skin Absorption |
|
5.2 |
Transport and Distribution |
|
5.3 |
Biotransformation |
|
5.4 |
Excretion |
|
5.5 |
Biological Half-Time |
|
5.6 |
Mechanisms of Arsenical Toxicity |
|
5.6.1 |
Mechanisms of Arsenical Metabolism and Toxicity |
|
5.6.2 |
Metabolism |
|
5.6.3 |
Mechanisms of Arsenical Toxicity |
|
6 |
Biological Monitoring |
|
6.1 |
Organs |
|
6.2 |
Urine |
|
6.3 |
Blood |
|
6.4 |
Hair |
|
7 |
Effects |
|
7.1 |
Lethality |
|
7.2 |
Acute and Subacute Effects |
|
7.3 |
Chronic Noncardiovascular Effects |
|
7.3.1 |
Dermal Effects |
|
7.3.2 |
Gastrointestinal Effects |
|
7.3.3 |
Neural Effects |
|
7.3.4 |
Hepatic Effects |
|
7.3.5 |
Hematological Effects |
|
7.3.6 |
Respiratory Effects |
|
7.3.7 |
Metabolic Effects |
|
7.3.8 |
Immunological Effects |
|
7.3.9 |
Ophthalmic Effects |
|
7.4 |
Chronic Cardiovascular Effects |
|
7.4.1 |
Cardiac Effects |
|
7.4.2 |
Peripheral Vascular Diseases |
|
7.4.3 |
Ischemic Heart Diseases |
|
7.4.4 |
Stroke |
|
7.4.5 |
Carotid Atherosclerosis |
|
7.4.6 |
Hypertension |
|
7.4.7 |
Microcirculation Abnormality |
|
7.5 |
Carcinogenic Effects |
|
7.5.1 |
Skin Cancer |
|
7.5.2 |
Lung Cancer |
|
7.5.3 |
Urothelial Cancer |
|
7.5.4 |
Liver Cancer |
|
7.5.5 |
Other Internal Cancers |
|
7.5.6 |
Lifetime Cancer Risk Induced by Arsenic |
|
7.6 |
Experimental System Cancer Studies |
|
7.6.1 |
Developmental and Reproductive Effects |
|
7.6.2 |
Genetoxic Effects and Mutagenicity |
|
7.7 |
Interaction Between Arsenic and Other Compounds |
|
8 |
Dose-Effect and Dose-Response Relationship in Arsenic Poisoning |
|
9 |
Diagnosis, Treatment, and Prognosis |
|
9.1 |
Acute Poisoning |
|
9.1.1 |
Inhalation Diagnosis |
|
9.1.2 |
Ingestion Diagnosis |
|
9.2 |
Chronic Poisoning |
|
9.2.1 |
Diagnosis |
|
9.2.2 |
Treatment and Prognosis |
|
10 |
Arsine |
|
10.1 |
Experimental Model Studies |
|
Chapter 20 |
Barium Agneta Oskarsson and Andrew L Reeves |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Soil, Water, and Air |
|
4.1.2 |
Plants, Animals, and Dietary Intake |
|
4.2 |
Working Environment |
|
5 |
Kinetics |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.1.3 |
Parenteral Administration |
|
5.2 |
Transport and Distribution |
|
5.3 |
Excretion |
|
6 |
Biological Monitoring |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Humans |
|
7.1.1 |
Acute Effects |
|
7.1.2 |
Chronic Effects |
|
7.2 |
Animals |
|
7.2.1 |
inhalation |
|
7.2.2 |
Ingestion |
|
8 |
Treatment |
|
Chapter 21 |
Beryllium Marek Jakubowski and Cezary Palczynski |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Soil, Water, and Air |
|
4.1.2 |
Plants, Animals, and Dietary Intake |
|
4.1.3 |
Estimates of Daily Exposure |
|
4.2 |
Working Environment |
|
5 |
Kinetics |
|
5.1 |
Absorption |
|
5.1.1 |
Dermal Exposure |
|
5.1.2 |
Inhalation |
|
5.1.3 |
Ingestion |
|
5.2 |
Transport, Distribution, and Excretion |
|
6 |
Levels in Tissues and Biological Fluids—Biological Monitoring |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects |
|
7.1.1 |
Skin Contact |
|
7.1.2 |
Inhalation |
|
7.2 |
Systemic Effects |
|
7.2.1 |
Acute Effects |
|
7.2.2 |
Chronic Beryllium Disease (CBD, Chronic Pulmonary Granulomatosis, Berylliosis) |
|
7.2.3 |
Other Chronic Systemic Effects |
|
7.3 |
Carcinogenic Effects |
|
7.3.1 |
Humans |
|
7.3.2 |
Animals |
|
7.4 |
Genotoxic Effects |
|
7.5 |
Mechanisms of Toxic Action |
|
7.6 |
Biomarkers of Effect |
|
7.7 |
Biomarkers of Susceptibility |
|
8 |
Diagnosis and Treatment |
|
8.1 |
Treatment |
|
Chapter 22 |
Bismuth Bruce A Fower and Mary J Sexton |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Food |
|
4.1.2 |
Ambient Air Water Soil and Rocks |
|
4.1.3 |
Pharmaceuticals and Cosmetics |
|
4.2 |
Working Environment |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Half-Times |
|
6 |
Biological Monitoring |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects and Dose-Response Relationships |
|
7.1.1 |
Animals |
|
7.1.2 |
Humans |
|
7.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2.1 |
Animals |
|
7.2.2 |
Humans |
|
7.3 |
Carcinogenicity Teratogenicity and Mutagenicity |
|
8 |
Treatment of Bismuth Poisoning |
|
Chapter 23 |
Cadmium Gunnar F. Nordberg Koji Nogawa Monica Nordberg Lars T. Friberg |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Food and Daily Intake |
|
4.1.2 |
Water and Soil |
|
4.1.3 |
Ambient Air |
|
4.1.4 |
Tobacco |
|
4.2 |
Working Environment |
|
5 |
Toxicokinetics |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.2 |
Transport and Distribution |
|
5.2.1 |
Systemic Transport |
|
5.2.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Half-Life |
|
5.5 |
Mathematical Models for Cd Accumulation in Renal Cortexand Other Tissues |
|
6 |
Biological Monitoring |
|
6.1 |
Biomarkers of Exposure |
|
6.1.1 |
Cd in Blood |
|
6.1.2 |
Cd in Urine |
|
6.1.3 |
Cadmium in Placenta |
|
6.1.4 |
Cd in Hair, Feces, and Other Biological Materials |
|
6.1.5 |
Cd in Kidney and Liver, Measured In Vivo, Body Burden |
|
6.2 |
Biomarkers of Effects |
|
7 |
Effects and Dose-Response Relationship |
|
7.1 |
Acute Poisoning |
|
7.1.1 |
Inhalation |
|
7.1.2 |
Ingestion |
|
7.2 |
Chronic Poisoning |
|
7.2.1 |
General Aspects |
|
7.2.2 |
Pulmonary Disorders |
|
7.2.3 |
Kidney Damage |
|
7.2.4 |
Anemia |
|
7.2.5 |
Blood Pressure |
|
7.2.6 |
Liver Disturbances |
|
7.2.7 |
Effects on Bone |
|
7.2.8 |
Itai-Itai Disease |
|
7.2.9 |
Cadmium and the Central and Peripheral Nervous System |
|
7.2.10 |
Reproductive and Developmental Effects |
|
7.3 |
Carcinogenic- Effects |
|
7.4 |
Genetic Effects |
|
7.5 |
Interaction Between Cadmium and Other Metals |
|
7.5.1 |
Cadmium-Zinc-Metallothionein, Iron, and Calcium |
|
7.5.2 |
Interaction Between Arsenic and Cadmium |
|
8 |
Dose-Response Relationships |
|
8.1 |
Critical Concentration in the Kidney and Toxicokinetic Model |
|
8.2 |
Direct Observations of Dose-Response and Risk Characterization |
|
9 |
Life Prognosis |
|
10 |
Diagnosis, Treatment, Prognosis, and Prevention |
|
10.1 |
Acute Poisoning |
|
10.1.1 |
Inhalation |
|
10.1.2 |
Ingestion |
|
10.2 |
Chronic Intoxication |
|
10.2.1 |
Diagnosis |
|
10.2.2 |
Treatment, Prognosis, and Prevention |
|
Chapter 24 |
Chromium Sverre Langard and Max Costa |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods of Chemical Analysis |
|
3 |
Manufacture and Uses |
|
3.1 |
Manufacture |
|
3.2 |
Uses |
|
4 |
Concentrations in the Environment |
|
4.1 |
Occurrence in Natural Environments and Soil |
|
4.2 |
Concentrations in Food |
|
4.3 |
Water and Ambient Air |
|
4.4 |
Tobacco |
|
4.5 |
Daily Intake in Humans |
|
5 |
Work-Related Exposure |
|
6 |
Uptake and Metabolism |
|
6.1 |
Dietary Intake |
|
6.2 |
Inhalation |
|
6.3 |
Distribution |
|
6.4 |
Excretion and Biological Half-Life |
|
6.5 |
Concentrations in Biological Fluids and Tissues |
|
7 |
Dose and Outcome Effects |
|
7.1 |
Local Effects |
|
7.1.1 |
Animals |
|
7.1.2 |
Humans |
|
7.2 |
Systemic Effects and Dose-Effect and Dose-Response |
|
7.2.1 |
Animals |
|
7.2.2 |
Humans |
|
7.3 |
Carcinogenic, Mutagenic, and Teratogenic Effects |
|
7.3.1 |
Animals |
|
7.3.2 |
Humans |
|
7.3.3 |
Interaction with Other Carcinogenic Factors |
|
7.3.4 |
Mutagenic and Genotoxic Effects |
|
7.3.5 |
Teratogenic Effects |
|
8 |
Biological Monitoring |
|
8.1 |
Biomarkers of Exposure |
|
8.2 |
Biomarkers of Effects |
|
9 |
Cellular Mechanism of Toxicity and Carcinogenicity |
|
9.1 |
Molecular Toxicology of Cr |
|
10 |
Diagnosis, Treatment, Prognosis, and Prevention |
|
Chapter 25 |
Cobalt Dominique Lison |
|
1 |
Physical and Chemical Properties |
|
2 |
Analytical Methods |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Food and Daily Intake |
|
4.1.2 |
Soil, Ambient Air, and Water |
|
4.2 |
Occupational Environment |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.1.1 |
Animal Studies |
|
5.1.2 |
Humans |
|
5.2 |
Distribution |
|
5.2.1 |
Animal Studies |
|
5.2.2 |
Humans |
|
5.3 |
Excretion |
|
5.3.1 |
Animal Studies |
|
5.3.2 |
Humans |
|
6 |
Biological Monitoring |
|
6 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects |
|
7.2 |
Respiratory Effects |
|
7.2.1 |
Upper Respiratory Tract |
|
7.2.2 |
Bronchial Tree |
|
7.2.3 |
Lung Parenchyma |
|
7.3 |
Other Systemic Effects |
|
7.3.1 |
Blood |
|
7.3.2 |
Myocardium |
|
7.3.3 |
Thyroid Gland |
|
7.4 |
Mutagenic Effects |
|
7.4.1 |
Experimental Data |
|
7.4.2 |
Human Data |
|
7.5 |
Carcinogenic Effects |
|
7.5.1 |
Animal Data |
|
7.5.2 |
Human Data |
|
7.6 |
Reprotoxicity |
|
7.6.1 |
Effects on Reproductive Organs and Fertility |
|
7.6.2 |
Developmental Effects |
|
Chapter 26 |
Copper Dag G. Ellingsen Nina Horn and Jan Aaseth |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
Food and Daily Intake |
|
4.2 |
Water, Soil, and Ambient Air |
|
4.3 |
Working Environment |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.2 |
Distribution |
|
5.2.1 |
Interorgan and Intracellular Distribution |
|
5.2.2 |
Molecular Genetics of Intracellular Transport |
|
5.2.3 |
Uptake into the Brain |
|
5.3 |
Genetic Disorders with a Disturbed Copper Metabolism |
|
5.4 |
Excretion |
|
5.5 |
Biological Half-Time |
|
6 |
Levels in Tissues and Biological Fluids |
|
6.1 |
Biological Monitoring |
|
6.2 |
Biomarkers of Exposure |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects and Dose-Response Relationships |
|
7.1.1 |
Animals |
|
7.1.2 |
Humans |
|
7.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2.1 |
Laboratory and Domestic Animals |
|
7.2.2 |
Humans |
|
7.3 |
Mutagenic, Carcinogenic, and Teratogenic Effects |
|
7.4 |
Biological Interaction |
|
8 |
Preventive Measures and Treatment |
|
Chapter 27 |
Gallium and Semiconductor Compound: Bruce A Fowler and Mary J. Sexton |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
Food and Daily Intake |
|
4.2 |
Water, Sediments, Soil, and Ambient Air |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Half-Time |
|
6 |
Levels in Biological Fluids |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Animal Studies |
|
7.2 |
Human Studies |
|
7.2.1 |
Toxicity |
|
7.2.2 |
Therapeutic |
|
Chapter 28 |
Germanium Obaid M. Faroon L. Samuel Keith Huch Hansen and Bruce A. Fowler |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
Food and Daily Intake |
|
4.1.1 |
Water, Soil, and Ambient Air |
|
4.1.2 |
Plants, Fishery Products, and Microbial Organisms |
|
4.2 |
Working Environment |
|
5 |
Toxicokinetics |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.1 |
Ingestion |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Half-Time |
|
6 |
Levels in Tissues and Biological Fluids—Biological Monitoring |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Inorganic compounds |
|
7.1.1 |
Local Effects and Dose-Response Relationships |
|
7.1.2 |
Systemic Effects and Dose-Response Relationships |
|
7.1.3 |
Humans |
|
7.2 |
Organometallic Compounds |
|
7.3 |
Carcinogenicity Mutagenicity and Teratogenicity |
|
8 |
Treatment Trials |
|
Chapter 29 |
Indium Bruce A. Fowler |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
Food and Daily Intake |
|
4.2 |
Water, Soil, and Ambient Air |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Half-Time |
|
6 |
Levels in Tissues and Biological Fluids |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects and Dose -Response Relationships |
|
7.1.1 |
Animals |
|
7.1.2 |
Humans |
|
7.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2.1 |
Animals |
|
7.2.2 |
Humans |
|
7.3 |
Carcinogenicity, Mutagenicity, and Teratogenicity |
|
7.4 |
Interactions with Ferric Dextran, Thorium Dioxide Sol, and Gelatin |
|
Chapter 30 |
Iron Prem Ponka Milton Tenenbein and John W. Eaton |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
4 |
Environmental Levels and Exposures |
|
5 |
Biological Function and Metabolism |
|
5.1 |
Overview of Iron Metabolism |
|
5.2 |
Cellular Iron Acquisition from Transferrin |
|
5.3 |
Iron Export from Cells to Transferrin |
|
5.4 |
Recycling of Hemoglobin Iron |
|
5.5 |
Iron Absorption |
|
5.6 |
Control of Cellular Iron Homeostasis |
|
6 |
Pathophysiology of Iron Metabolism |
|
6.1 |
Diseases of Iron Deficiency |
|
6.2 |
Diseases of Iron Overload |
|
6.3 |
Mechanisms of Tissue Damage in Iron Overload |
|
6.3.1 |
Compensatory Responses to Oxidation/Iron Overload MayLimit Early Damage |
|
6.3.2 |
Iron-Driven Cellular Damage Involves Oxidative Reactions |
|
6.3.3 |
Polyunsaturated Fatty Acids |
|
6.3.4 |
DNA |
|
6.3.5 |
Proteins |
|
6.3.6 |
Iron-Mediated Damage to Mitochondria |
|
6.3.7 |
Iron-Mediated Destabilization of Lysosomal Membranes |
|
7 |
“Carcinogenic” Effects |
|
7.1 |
Role of Iron in DNA Synthesis and Cell Proliferation |
|
7.2 |
Evidence That Iron Promotes Carcinogenesis in Humans Is Lacking |
|
8 |
Iron Poisoning |
|
8.1 |
Introduction |
|
8.2 |
Iron Preparations |
|
8.3 |
Pathophysiology |
|
8.4 |
Clinical Presentation |
|
8.4.1 |
Gastrointestinal Toxicity |
|
8.4.2 |
Relative Stability |
|
8.4.3 |
Circulatory Shock and Metabolic Acidosis |
|
8.4.4 |
Hepatotoxicity |
|
8.4.5 |
Gastrointestinal Scarring |
|
8.5 |
Iron Overdose During Pregnancy |
|
8.6 |
Laboratory Evaluation |
|
8.7 |
Treatment |
|
8.8 |
Prevention |
|
9 |
Conclusions |
|
Chapter 31 |
Lead Staffan Skerfving and Ingvar A. Bergdahl |
|
1 |
Background |
|
2 |
Inorganic Lead |
|
2.1 |
Physical and Chemical Properties |
|
2.2 |
Methods and Problems of Analysis |
|
2.2.1 |
Blood Analysis |
|
2.2.2 |
Air, Water, Soil, and Sediments |
|
2.2.3 |
Specialized Techniques |
|
2.3 |
Production and Uses |
|
2.4 |
Exposure |
|
2.4.1 |
General Environment |
|
2.4.2 |
Occupational Environments |
|
2.5 |
Toxicokinetics |
|
2.5.1 |
Absorption |
|
2.5.2 |
Distribution |
|
2.5.3 |
Biotransformation |
|
2.5.4 |
Elimination |
|
2.5.5 |
Biokinetics |
|
2.5.6 |
Gene-Environment Interaction |
|
2.6 |
Biological Monitoring |
|
2.6.1 |
Biomarkers of Exposure |
|
2.6.2 |
Biomarkers of Effects |
|
2.6.3 |
Summary |
|
2.7 |
Organ Effects |
|
2.7.1 |
Nervous System |
|
2.7.2 |
Blood and Blood-Forming Organs |
|
2.7.3 |
Kidneys |
|
2.7.4 |
Cardiovascular System |
|
2.7.5 |
Endocrine System |
|
2.7.6 |
Gastrointestinal Tract |
|
2.7.6 |
Other Organs |
|
2.8 |
Immunotoxicology |
|
2.9 |
Mutagenicitx |
|
2.10 |
Cancer |
|
2.11 |
Reproduction |
|
2.11.2 |
Females and Offspring |
|
2.11.2 |
Males |
|
2.12 |
Overall Assessment of Risk |
|
2.12.1 |
The Data Sets—Strengths and Limitations |
|
2.12.2 |
Effects and Their Relation to Exposure |
|
2.13 |
Exposure Standards and Classifications |
|
2.13.1 |
Occupational Exposure Limits (OELs) |
|
2.13.2 |
Other Assessments |
|
2.14 |
Diagnosis, Treatment, and Prognosis of Poisoning and Medical Surveillance |
|
2.14.1 |
Diagnosis |
|
2.14.2 |
Treatment |
|
2.14.3 |
Prognosis |
|
2.14.4 |
Medical Surveillance |
|
3 |
Organic Lead |
|
3.1 |
Physical and Chemical Properties |
|
3.2 |
Methods and Problems of Analysis |
|
3.3 |
Production and Uses |
|
3.4 |
Exposure |
|
3.5 |
Toxicokinetics |
|
3.6 |
Biological Monitoring |
|
3.6.1 |
Biomarkers of Exposure |
|
3.6.2 |
Biomarkers of Effects |
|
3.7 |
Organ Effects |
|
3.7.1 |
Nervous System |
|
3.7.2 |
Other |
|
3.8 |
Diagnosis, Treatment, and Prognosis |
|
Chapter 32 |
Manganese Markosaric and Roberto Lucchini |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Occurrence, Production, and Uses |
|
3.1 |
Occurrence and Production |
|
3.2 |
Uses |
|
4 |
Levels and Fate in the Environment and Exposure |
|
4.1 |
General Environment |
|
4.1.1 |
Ambient Air |
|
4.1.2 |
Water |
|
4.1.3 |
Soil |
|
4.2 |
Food |
|
4.3 |
Working Environment |
|
5 |
Toxicokinetics |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.12 |
Ingestion |
|
5.1.3 |
Dermal Exposure |
|
5.2 |
Distribution |
|
5.3 |
Metabolism |
|
5.4 |
Excretion |
|
6 |
Health Effects |
|
6.1 |
Manganese Deficiency |
|
6.2 |
Acute Effects |
|
6.3 |
Adverse Effects of Prolonged Exposure |
|
6.3.1 |
Neurotoxic Effect |
|
6.4 |
Effect on the Lungs |
|
6.4.1 |
Mode of Action |
|
6.4.2 |
Human Studies of Lung Impairment |
|
6.5 |
Effects on Other Organs and Systems |
|
6.5.1 |
Reproductive Effects |
|
6.5.2 |
Cardiovascular Effects |
|
6.5.3 |
Hematological Effects |
|
6.5.4 |
Endocrine Effects |
|
6.5.5 |
Immunological Effects |
|
6.5.6 |
Genotoxic and Carcinogenic Effects |
|
7 |
Guidelines/Regulations |
|
8 |
Manganese Concentrations in Biological Media and Biomarkers of Exposure and Effects |
|
Chapter 33 |
Mercury Maths |
|
1 |
Introduction |
|
2 |
Physical and Chemical Properties |
|
3 |
Methods and Problems of Analysis |
|
4 |
Production and Uses |
|
4.1 |
Production |
|
4.2 |
Uses |
|
5 |
Environmental Levels and Exposures |
|
5.1 |
General Environment |
|
5.1.1 |
Food and Daily Intake |
|
5.1.2 |
Water |
|
5.1.3 |
Ambient Air |
|
5.1.4 |
Soils and Sediments |
|
5.2 |
Working Environment |
|
6 |
Metabolism and Toxic Effects of Elemental Mercury and Inorganic Mercury Compounds |
|
6.1 |
Elemental Mercury |
|
6.1.1 |
Metabolism |
|
6.1.2 |
Symptoms and Signs in Poisoning Caused by Exposure to Mercury Vapor |
|
6.1.3 |
Indicators of Exposure and Concentration in the Critical Organ |
|
6.1.4 |
Dose-Response Relationships |
|
6.2 |
Mercuric Mercury |
|
6.2.1 |
Metabolism |
|
6.2.2 |
Symptoms and Signs in Poisoning Caused by Mercuric Salts |
|
6.2.3 |
Indicators of Exposure and Concentration in the Critical Organ |
|
6.2.4 |
Dose-Effect and Dose-Response Relationships on Exposure to Mercuric Salts |
|
6.2.5 |
Factors Interacting with the Toxicity of Mercuric Mercury |
|
7 |
Metabolism and Toxic Effects of Organic Mercury Compounds |
|
7.1 |
Organic Compounds Relatively Stable in the Mammalian Body |
|
7.1.1 |
Metabolism Absorption—Inhalation |
|
7.1.2 |
Toxic Effects and Mechanisms |
|
7.1.3 |
Symptoms and Signs in Poisoning Caused by Exposure to Alkylmercury |
|
7.1.4 |
Indicators of Exposure and Concentration in the Critical Organ |
|
7.1.5 |
Dose-Response Relationships |
|
8 |
Prevention, Prognosis, and Treatment |
|
8.1 |
Mercury Vapor |
|
8.2 |
Inorganic Mercuric Mercury |
|
8.3 |
Short-Chain Alkylmercury |
|
8.4 |
Phenylmercury Compounds or Methoxyethylmercury Compounds |
|
8.5 |
Long-Term Therapy in Chronic Exposed Cases |
|
Chapter 34 |
Molybdenum Judith R. Turnkund and Lars T. Friberg |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposure |
|
4.1 |
Food and Daily Intake |
|
4.2 |
Water, Soil, and Ambient Air |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Half-Life |
|
5.5 |
Molybdenum Deficiency |
|
5.6 |
Dietary Requirements and Recommendations |
|
6 |
Biological Monitoring |
|
6.1 |
Biomarkers of Exposure |
|
6.2 |
Biomarkers of Effects |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects and Dose-Response Relationships |
|
7.1.1 |
Animals |
|
7.1.2 |
Humans |
|
7.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2.1 |
Laboratory Animals |
|
7.2.2 |
Livestock |
|
7.2.3 |
Humans |
|
7.3 |
Interaction with Copper and Sulfur |
|
Chapter 35 |
Nickel Catherine Klien and Max Costa |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Air Soil and Water |
|
4.1.2 |
Food Intake |
|
4.1.3 |
Skin Absorption |
|
4.1.4 |
Tobacco |
|
4.2 |
Working Environment |
|
5 |
Metabolism |
|
5.1 |
Essentiality |
|
5.2 |
Absorption |
|
5.3 |
Transport |
|
5.4 |
Excretion |
|
5.5 |
Biological Half-Time |
|
6 |
Biological Monitoring |
|
6.1 |
Levels in Human Tissues and Fluids |
|
6.2 |
Biomarkers of Exposure |
|
7 |
Toxicological Effects |
|
7.1 |
General Systemic Effects in Animals and Humans |
|
7.2 |
Inhalation Effects in Animals and Humans |
|
7.3 |
Skin Effects in Animals and Humans |
|
7.4 |
Injection Site Effects in Animals |
|
7.5 |
Teratogenicity |
|
8 |
Genotoxicity and Carcinogenicity |
|
8.1 |
Genotoxicity and Mutagenicity |
|
8.2 |
Carcinogenicity in Animals and Humans |
|
8.2.1 |
Animals |
|
8.2.2 |
Humans |
|
9 |
Effects on Gene Expression and Signaling Pathways |
|
10 |
Epigenetic Effects |
|
10.1 |
Effects on DNA Methylation and Epigenetic Silencing |
|
10.2 |
Effects on Histone Acetylation |
|
11 |
Treatment of Nickel Carbonyl Poisoning |
|
Chapter 36 |
Palladium Hiroshi Satoh |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
Water, Soil, and Ambient Air |
|
4.2 |
Food and Daily Intake |
|
4.3 |
Working Environment |
|
4.4 |
Iatrogenic Exposure |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
6 |
Levels in Tissues and Biological Fluids |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Animals |
|
7.1.1 |
Single Exposure |
|
7.1.2 |
Repeated Exposure |
|
7.1.3 |
Chronic Exposure |
|
7.1.4 |
Irritation and Sensitization |
|
7.1.5 |
DNA Interactions and Mutagenicity |
|
7.1.6 |
Carcinogenicity |
|
7.2 |
Humans |
|
7.2.1 |
General Population Exposure |
|
7.2.2 |
Iatrogenic Exposure |
|
7.2.3 |
Occupational Exposure |
|
7.2.3 |
Carcinogenicity and Other Effects |
|
7.3 |
Dose-Response Relationships |
|
8 |
Diagnosis, Treatment, Prognosis, and Prevention |
|
Chapter 37 |
Platinum Mirja Kiilunen and Antero Aitio |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposure |
|
4.1 |
General Environment |
|
4.2 |
Working Environment |
|
4.3 |
Food |
|
5 |
Kinetics and Metabolism |
|
5.1 |
Absorption Distribution and Excretion |
|
5.2 |
Reference Values in Tissues and Biological Fluids |
|
5.3 |
Biological Monitoring |
|
6 |
Effects in Animals and Humans and Dose-Response Relationships |
|
6.1 |
Acute Toxicity |
|
6.2 |
Sensitization |
|
6.3 |
Carcinogenicity, Mutagenicity, and Reproductive Effects |
|
7 |
Risk Assessment |
|
Chapter 38 |
Selenium Johan Hogberg and Jan Alexander |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposure |
|
4.1 |
General Environment |
|
4.1.1 |
Food and Daily Intake |
|
4.1.2 |
Ambient Air |
|
4.1.3 |
Water |
|
4.1.4 |
Rocks and Soil |
|
4.1.5 |
Plants |
|
4.1.6 |
Tobacco |
|
4.2 |
Work Environment |
|
5 |
Biological Function and Metabolism |
|
5.1 |
Biological Functions |
|
5.2 |
Selenium Deficiency and Diseases Related to Selenium Status |
|
5.2.1 |
Animals |
|
5.2.2 |
Selenium and Cardiovascular Diseases |
|
5.2.3 |
Selenium and Cancer |
|
5.2.4 |
Infectious Diseases |
|
5.2.5 |
Other Diseases |
|
5.3 |
Kinetics |
|
5.3.1 |
Absorption |
|
5.3.2 |
Distribution |
|
5.3.3 |
Biotransformation |
|
5.3.4 |
Excretion |
|
5.3.5 |
Biological Half-Time |
|
6 |
Biological Monitoring |
|
6.1 |
Levels in Tissues and Biological Fluids |
|
6.2 |
Biomarkers of Exposure |
|
6.3 |
Biomarkers of Effect |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Acute Toxicity |
|
7.1.1 |
Laboratory Animals |
|
7.1.2 |
Humans |
|
7.2 |
Chronic Toxicity |
|
7.2.1 |
Laboratory Animals |
|
7.2.2 |
Domestic Animals |
|
7.2.3 |
Humans |
|
7.3 |
Other Diseases Related to Selenium Overexposure |
|
7.4 |
Mutagenic Effects |
|
7.5 |
Carcinogenic Effects |
|
7.5.1 |
Animals |
|
7.5.2 |
Humans |
|
7.6 |
Reproductive and Developmental Effects |
|
7.7 |
Interactions with Metals |
|
7.7.1 |
Arsenic |
|
7.7.2 |
Bismuth |
|
7.7.3 |
Cadmium |
|
7.7.4 |
Cobalt |
|
7.7.5 |
Copper |
|
7.7.6 |
Lead |
|
7.7.7 |
Mercury |
|
7.7.8 |
Platinum |
|
7.7.9 |
Silver |
|
7.7.10 |
Tellurium |
|
7.7.11 |
Thallium |
|
8 |
Prevention, Diagnosis, Prognosis and Treatment |
|
Chapter 39 |
Silver James S. Holler Gunnar F. Nordberg and Bruce A. Fowler |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Food and Daily Intake |
|
4.1.2 |
Water, Soil, and Ambient Air |
|
4.1.3 |
Tobacco |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Half-Time |
|
6 |
Levels in Tissues and Biological Fluids—Reference Values |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects and Dose-Response Relationships |
|
7.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2.1 |
Animals |
|
7.2.2 |
Humans |
|
7.3 |
Interactions with Selenium, Copper, and Vitamin E |
|
8 |
Treatment |
|
Chapter 40 |
Tellurium Lars gerhardsson |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Food and Daily Intake |
|
4.1.2 |
Water, Soil, and Ambient Air |
|
4.1.3 |
Plants |
|
4.2 |
Working Environment |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.1.3 |
Skin Absorption |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Half-Time |
|
6 |
Biological Monitoring |
|
6.1 |
Levels in Tissues and Biological Fluids |
|
6.2 |
Biomarkers of Exposure |
|
6.3 |
Biomarkers of Effects |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects and Dose-Response Relationships |
|
7.1.1 |
Animals |
|
7.1.2 |
Humans |
|
7.2 |
Systemic Effects and Dose-Response Relationships |
|
7.1.1 |
Animals |
|
7.1.2 |
Humans |
|
7.2.3 |
Summary of Systemic Effects |
|
8 |
Carcinogenicity and Mutagenicity |
|
9 |
Diagnosis, Prevention, and Treatment of Tellurium Poisoning |
|
10 |
Standards—Threshold Limit Values |
|
Chapter 41 |
Thallium George Kanzantzis |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
4 |
Environmental Levels and Exposure |
|
4.1 |
General Environment |
|
4.2 |
Working Environment |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Half-Time |
|
6 |
Biological Monitoring |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Laboratory Animals |
|
7.2 |
Domestic and Wild Animals |
|
7.3 |
Humans |
|
7.4 |
Interaction with Potassium and Other Effects |
|
8 |
Diagnosis, Treatment, and Preventive Measures |
|
9 |
Prognosis |
|
Chapter 42 |
Tin Elena A. Ostrakhovitch and M. Georgre Cherian |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Food and Daily Intake |
|
4.1.2 |
Water, Soil, and Air |
|
4.2 |
Working Environment |
|
5 |
Metabolism |
|
5.1 |
Inorganic Tin |
|
5.1.2 |
Absorption |
|
5.1.2 |
Distribution |
|
5.1.3 |
Excretion |
|
5.1.4 |
Biological Half-Life |
|
5.1.5 |
Biotransformation |
|
5.2 |
Organotin Compounds |
|
5.2.1 |
Absorption |
|
5.2.2 |
Distribution |
|
5.2.3 |
Excretion |
|
5.2.4 |
Biological Half-Life |
|
5.2.5 |
Biotransformation |
|
6 |
Levels in Tissue and Biological Fluids |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Inorganic Tin |
|
7.1.1 |
Local Effects and Dose-Response Relationships |
|
7.1.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2 |
Organotin |
|
7.2.1 |
Local Effects and Dose-Response Relationships |
|
7.2.2 |
Systemic Effects and Dose-Response Relationships |
|
7.3 |
Mechanism of Action |
|
Chapter 43 |
Titanium Taiyi Jin and Maths |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Food and Daily Intake |
|
4.1.2 |
Water, Soil, and Ambient Air |
|
4.2 |
Working Environment |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.2 |
Distribution |
|
5.3 |
Biological Half-Time |
|
5.4 |
Excretion |
|
6 |
Levels in Tissues and Biological Fluids |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects and Dose-Response Relationships |
|
7.1.1 |
Animals |
|
7.1.2 |
Humans |
|
7.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2.1 |
Animals |
|
7.2.2 |
Humans |
|
7.3 |
Mutagenicity, Carcinogenicity, Teratogenicity, and Effects on Reproduction |
|
7.3.1 |
Animals |
|
7.3.2 |
Human |
|
Chapter 44 |
Tungsten George Kazantzis and Per Leffler |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.2 |
Working Environment |
|
5 |
Metabolism |
|
5.1 |
Absorption |
|
5.2 |
Distribution |
|
5.3 |
Excretion |
|
5.4 |
Biological Half-Time |
|
6 |
Biological Monitoring |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects and Dose-Response Relationships |
|
7.1.1 |
Animals |
|
7.1.2 |
Humans |
|
7.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2.1 |
Animals |
|
7.2.2 |
Humans |
|
7.3 |
Interaction with Molybdenum |
|
Chapter 45 |
Uranium L. Samuel Keith Obaid M. Faroon and Bruce A. Fowler |
|
1 |
Physical Chemical and Radiological Properties |
|
2 |
Analytical Methods |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
Environmental Levels and Human Exposure |
|
4.1.1 |
Food and Daily Intake |
|
4.1.2 |
Water |
|
4.1.3 |
Soil and Rock |
|
4.1.4 |
Air |
|
4.1.5 |
Other |
|
4.2 |
Working Environment |
|
4.3 |
Remediation |
|
5 |
Toxicokinetics |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.1.3 |
Dermal Exposure |
|
5.2 |
Metabolism and Distribution |
|
5.3 |
Elimination and Excretion |
|
6 |
Mechanisms of Action |
|
6.1 |
Chemical versus Radiological |
|
6.2 |
Route of Exposure |
|
6.3 |
Hepatic Mechanisms |
|
6.4 |
Immunological Mechanisms |
|
6.5 |
Pulmonary Mechanisms |
|
6.6 |
Renal Mechanisms |
|
6.7 |
Skeletal Mechanism |
|
6.8 |
Summary on Mechanisms |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Organ and Tissue Effects |
|
7.1.1 |
Cancer |
|
7.1.2 |
Dermal Effects |
|
7.1.3 |
Developmental Effects |
|
7.1.4 |
Hepatic Effects |
|
7.1.5 |
Neurological Effects |
|
7.1.1 |
Pulmonary Effects |
|
7.1.7 |
Renal Effects |
|
7.1.8 |
Reproductive Effects |
|
7.2 |
Health Guidance Values |
|
8 |
Biomarkers |
|
8.1 |
Biomarkers Used to Assess Exposure |
|
8.2 |
Biomarkers Used to Characterize Effect |
|
9 |
Treatment Methods for Reducing Toxic Effects |
|
Chapter 46 |
Vanadium Birgitta J-Son Lagerkvist and Agneta Oskarsson |
|
1 |
Physical and Chemical Properties |
|
2 |
Methods and Problems of Analysis |
|
3 |
Production and Uses |
|
3.1 |
Production |
|
3.2 |
Uses |
|
4 |
Environmental Levels and Exposures |
|
4.1 |
General Environment |
|
4.1.1 |
Food |
|
4.1.2 |
Air |
|
4.1.3 |
Mosses |
|
4.1.4 |
Water |
|
4.1.5 |
Soil |
|
4.1.6 |
Coal and Oil |
|
4.1.7 |
Work Environment |
|
5 |
Toxicokinetics |
|
5.1 |
Absorption |
|
5.1.1 |
Inhalation |
|
5.1.2 |
Ingestion |
|
5.1.3 |
Skin |
|
5.2 |
Distribution |
|
5.2.1 |
Animal Studies |
|
5.2.2 |
Human Studies |
|
5.3 |
Elimination and Biological Half-Time |
|
5.3.1 |
Animal Studies |
|
5.3.2 |
Human Studies |
|
6 |
Biological Monitoring |
|
7 |
Effects and Dose-Response Relationships |
|
7.1 |
Local Effects and Dose-Response Relationships |
|
7.1.1 |
Human Studies |
|
7.2 |
Systemic Effects and Dose-Response Relationships |
|
7.2.1 |
Animals |
|
7.2.2 |
Humans |
|
8 |
Treatment of Vanadium Poisoning |
|
Chapter 47 |
Zinc Harold H. Sandstead and William Au |
|
1 |
Identity and Physical/Chemical Properties |
|
2 |
Analytical Methods |
|
3 |
Sources of Human and Environmental Exposure |
|
3.1 |
Uses |
|
3.2 |
General Environment |
|
3.2.1 |
Atmosphere |
|
3.2.2 |
Water |
|
3.2.3 |
Soil |
|
4 |
Environmental Transport, Distribution, and
Transformation |
|
4.1 |
Air |
|
4.2 |
Water and Sediment |
|
4.3 |
Soil |
|
4.4 |
Biotransformation |
|
5 |
Environmental Levels and Human Exposure |
|
5.1 |
Air |
|
5.2 |
Water |
|
5.3 |
Soil |
|
5.4.1 |
Plants |
|
5.4.2 |
Flesh Foods |
|
5.4.3 |
Dairy Products |
|
5.4.4 |
Nutritional Supplements |
|
5.5 |
Work Environment |
|
5.5.1 |
Inhalation |
|
6 |
Biological Monitoring |
|
6.1 |
Direct Indicators of Zn Status |
|
6.1.1 |
History |
|
6.1.2 |
Plasma/Serum Zinc |
|
6.1.3 |
White Blood Cell Zinc |
|
6.1.4 |
HairZn |
|
6.1.5 |
Urine Zinc |
|
6.2 |
Indirect Physiological Indicators of Zn Status |
|
6.2.1 |
Alkaline Phosphatase |
|
6.2.2 |
Ecto 5’-Nucleotidase |
|
6.2.3 |
Immunity |
|
6.2.3 |
Neuropsychological Functions |
|
6.2.5 |
Dark Adaptation |
|
6.2.6 |
Taste Acuity |
|
6.2.7 |
Growth and Body Composition |
|
6.2.8 |
Physical Examination |
|
7 |
Effects on Laboratory Mammals |
|
7.1 |
Essentiality |
|
7.2 |
Deficiency |
|
7.3 |
Single Toxic Exposure of Animals |
|
7.4 |
Short-Term Exposure of Animals |
|
7.5 |
Long-Term Exposure and Carcinogenicity |
|
7.6 |
Reproductive Toxicity |
|
8 |
Effects on Humans |
|
8.1 |
Absorption |
|
8.2 |
Excretion |
|
8.3 |
Biological Half-Life |
|
8.4 |
Zinc Content of Tissues and Blood |
|
8.5 |
Essentiality and Requirements |
|
8.6 |
Bioavailability |
|
8.7 |
Methods for Determining Requirements |
|
8.8 |
Deficiency |
|
8.9 |
Dietary (Primary) Deficiency |
|
8.10 |
Conditioned (Secondary) Deficiency |
|
8 |
Toxicity |
|
8.7.1 |
Dietary and Supplement Intakes |
|
8.7.2 |
Reference Dose (RfD) |
|
8.7.3 |
Poisoning from Ingestion of Zinc-Contaminated
Food, Drink, and Other Substances |
|
8.7.4 |
Poisoning from Inhalation |
|
9 |
Effects Evaluation |
|
9.1 |
Homeostatic Model |
|
9.2 |
Risks to Human Health |
|
9.3 |
General Population |
|
9.4 |
Occupational Exposure |
|
9.5 |
Risk of Zn Deficiency |
|
9.6 |
Risk of Excess Zn |
|
9.7 |
Environmental Risk Assessment for Zn |
|
|
|